Semaglutide implant (Vivani Medical)

司美格鲁肽微型皮下植入物 (Vivani Medical)

Report date: 2026/04/03 20:03:44

Base Information

Drug NameSemaglutide implant (Vivani Medical)
Drug Alias NameNPM-139NPM-133
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsOverweightObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVivani Medical Inc
China Registration ClassN/A

Develop Information

Active CompaniesVivani Medical Inc
Inactive CompaniesN/A
Active IndicationsOverweightObesityDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A